Loss of SLC25A39 reduces mitochondrial GSH import and abundance without affecting cellular GSH levels
This is weight loss as platforma therapy whose economic value cannot be captured in a single disease model
Jan's trial concluded, and she was no longer able to take semaglutide
Associations of semaglutide with first-time diagnosis of Alzheimers disease in patients with type 2 diabetes: target trial emulation using nationwide real-world data in the US
You can flip to *any* chapter and discover the most up-to-date, research-proven, trench-tested techniques to build muscle, burn fat, balance hormones, live longer, sleep better, have mind-blowing sex, and much, much more
Treating all of them the same way is why people feel stuck